Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS)
Clinical trial NCT04856293 · COMPLETED
Trial details
- NCT number
- NCT04856293
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-16
- Primary completion
- 2021-12-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.